Anxo Pharmaceutical Co., Ltd.

TPEX:6677 주식 보고서

시가총액: NT$1.8b

Anxo Pharmaceutical 과거 수익 실적

과거 기준 확인 0/6

Anxo Pharmaceutical's earnings have been declining at an average annual rate of -24.1%, while the Pharmaceuticals industry saw earnings growing at 8.8% annually. Revenues have been growing at an average rate of 1.5% per year.

주요 정보

-24.1%

수익 성장률

-25.2%

EPS 성장률

Pharmaceuticals 산업 성장18.5%
매출 성장률1.5%
자기자본 수익률-1.0%
순이익-2.2%
최근 수익 업데이트30 Jun 2024

최근 과거 실적 업데이트

Recent updates

These 4 Measures Indicate That Anxo Pharmaceutical (GTSM:6677) Is Using Debt Extensively

Dec 30
These 4 Measures Indicate That Anxo Pharmaceutical (GTSM:6677) Is Using Debt Extensively

Should We Be Cautious About Anxo Pharmaceutical Co., Ltd.'s (GTSM:6677) ROE Of 2.4%?

Nov 25
Should We Be Cautious About Anxo Pharmaceutical Co., Ltd.'s (GTSM:6677) ROE Of 2.4%?

수익 및 비용 분석

Anxo Pharmaceutical 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

TPEX:6677 수익, 비용 및 수입 (TWD Millions )
날짜수익수익G+A 비용R&D 비용
30 Jun 24910-20221129
31 Mar 249251213134
31 Dec 2394022204139
30 Sep 2394128199141
30 Jun 2394133193144
31 Mar 2390410190142
31 Dec 22866-13186140
30 Sep 22830-17183134
30 Jun 22793-21180127
31 Mar 22809-1180119
31 Dec 2182419180111
30 Sep 2183519185111
30 Jun 2184519191110
31 Mar 2185625195105
31 Dec 2086631199101
30 Sep 208672519988
30 Jun 208671920076
31 Mar 208732220471
31 Dec 198782420767
30 Sep 198632020866
30 Jun 198471620864
31 Mar 198492221168
31 Dec 188502921471
30 Sep 188232021670
30 Jun 187951121869
31 Mar 18750-921863
31 Dec 17705-2921857
30 Sep 17692-2221858
30 Jun 17679-1521959
31 Mar 17660-1721857
31 Dec 16642-2021856
31 Dec 15631-2420931
31 Dec 146432618527

양질의 수익: 6677 is currently unprofitable.

이익 마진 증가: 6677 is currently unprofitable.


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: 6677 is unprofitable, and losses have increased over the past 5 years at a rate of 24.1% per year.

성장 가속화: Unable to compare 6677's earnings growth over the past year to its 5-year average as it is currently unprofitable

수익 대 산업: 6677 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-0.6%).


자기자본 수익률

높은 ROE: 6677 has a negative Return on Equity (-1.02%), as it is currently unprofitable.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기